ReviewFrontiers in pharmacology2018
The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD.
Mitsuhiro Yamada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it